Murata, Saori, et al. “The Change in Neutrophil-to-Lymphocyte Ratio After Initiation of Nivolumab Monotherapy May Be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-Small Cell Lung Carcinoma”. Asian Pacific Journal of Cancer Care, vol. 7, no. 1, Mar. 2022, pp. 191-6, doi:10.31557/apjcc.2022.7.1.191-196.